Skip to content

Anti Beta 2 Glycoprotein I Igm Antibody Positivity C5676753

Published: July 22, 2026Updated: August 20, 2026

IgM type antibodies against beta-2 glycoprotein I. May indicate increased clotting tendency and is often tested alongside other antiphospholipid markers. Treatment depends on overall clinical picture.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Arterial thrombosis

!

Pulmonary embolism

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Cutaneous ulceration

(skin)

Vasculitis

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Low-dose aspirin therapy

Antiplatelet therapy with low-dose aspirin is commonly prescribed to reduce thrombotic risk associated with antiphospholipid antibodies. Regular monitoring of bleeding parameters is essential during treatment.

medication
3

Anticoagulation therapy

Vitamin K antagonists such as warfarin may be prescribed for patients with confirmed antiphospholipid syndrome and history of thrombosis. INR monitoring is required regularly.

medication

Additional treatment options

Regular antibody and coagulation monitoring

Periodic testing of aPL titers and coagulation parameters helps assess disease activity and treatment response. Monitoring frequency depends on clinical status.

monitoring

Cardiovascular risk reduction

Lifestyle modifications including smoking cessation, regular exercise, and maintaining healthy weight reduce overall thrombotic risk. These changes complement medical therapy.

lifestyle

Hydroxychloroquine

Immunomodulatory agent that may be used as adjunctive therapy in antiphospholipid syndrome. Has anti-inflammatory and antithrombotic properties.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Beta 2 Glycoprotein I Igm Antibody Positivity C5676753?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006;4(2):295-306.

guideline2021
2

Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498-1509.

review2020
3

Quillen K, Kontopoulos N, Kada S, et al. Clinical significance of anti-beta-2 glycoprotein I antibodies: a systematic review and meta-analysis. Autoimmun Rev. 2019;18(8):745-753.

meta_analysis2019
4

Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-1304.

other2019

Medication Comparisons

Compare medications used to treat Anti Beta 2 Glycoprotein I Igm Antibody Positivity C5676753. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy